
In this episode of the Real Drug Talk podcast, Jack Nagle sits down with Dr. Jack Freestone, researcher and former manager of ACON’s LGBTQ+ drug and alcohol program, to explore the realities of chemsex, GHB use, and harm reduction strategies in Australia.
We dive deep into:
What chemsex actually is – and how it’s defined in research and community.
GHB trends and risks – why use is rising, overdose dangers, and myths about dependence.
Harm reduction strategies that work – from safe dosing and measuring to peer-led support.
The METHOD program – a peer-based service helping people reduce harm in sexualised drug use.
Barriers to AOD services – why talking about sex and drug use together is still taboo for many clients.
The Prompt Response Network – how Australia responds to emerging drug threats.
This conversation goes beyond headlines and stigma, offering a balanced look at drug use, sexuality, public health, and community-driven solutions.
📌 Resources & Links Mentioned:
METHOD Program (ACON) – Harm reduction for chemsex: Book A M3THOD Appointment | Party & Play Support | Ending HIV
The Know – National drug alerts: The Know - Australian drug alerts, all in one place
NCRED – National Centre for Clinical Research on Emerging Drugs: https://nccred.org.au/
Research study on chemsex & service experiences: Exploring experiences of talk therapies among gay and bisexual men seeking to reduce or abstain from using crystal methamphetamine in the context of chemsex - PubMed